Who
Michael J. Purcell
Director
Company insider
Files Form 4 as: Director, International Money Express; Director, Hepion Pharmaceuticals; Director, Tabula Rasa HealthCare; Director, Patriot National.
In numbers
- Trades disclosed
- 69
- Buys
- 5
- Sells
- 1
- Bought
- $737K
- Sold
- $43K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 1 Jan 2017
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,360 at $11.49 | filing |
| 19 Aug 2026filed 10 Sep 2026 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —299,000 at $0.00 | filing |
| 19 Aug 2026filed 10 Sep 2026 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —299,000 at $0.00 | filing |
| 3 Aug 2026filed 12 Aug 2026 | Hepion PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $100K2,000,000 at $0.05 | filing |
| 3 Aug 2026filed 12 Aug 2026 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,000,000 at $0.00 | filing |
| 3 Aug 2026filed 12 Aug 2026 | Hepion Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,000,000 at $0.00 | filing |
| 3 Aug 2026filed 12 Aug 2026 | Hepion PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $100K2,000,000 at $0.05 | filing |
| 16 Jul 2026filed 20 Jul 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $150K10,862 at $13.81 | filing |
| 16 Jul 2026filed 20 Jul 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $150K10,862 at $13.81 | filing |
| 1 Jul 2026filed 2 Jul 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,075 at $14.54 | filing |
| 1 Jul 2026filed 2 Jul 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,075 at $14.54 | filing |
| 21 Apr 2026filed 27 Apr 2026 | Hepion PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $50K1,250,000 at $0.04 | filing |
| 21 Apr 2026filed 27 Apr 2026 | Hepion PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $50K1,250,000 at $0.04 | filing |
| 1 Apr 2026filed 2 Apr 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K989 at $15.80 | filing |
| 1 Apr 2026filed 2 Apr 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K989 at $15.80 | filing |
| 1 Jan 2026filed 5 Jan 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,019 at $15.34 | filing |
| 1 Jan 2026filed 5 Jan 2026 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,019 at $15.34 | filing |
| 1 Oct 2025filed 2 Oct 2025 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,122 at $13.93 | filing |
| 1 Jul 2025filed 3 Jul 2025 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $16K1,482 at $10.54 | filing |
| 20 Jun 2025filed 24 Jun 2025 | IMXI International Money ExpressBusiness Services | SEC FORM 4 Code A | $150K14,867 at $10.09 | filing |
News
No headline names them, or the companies they trade most, lately.